Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals

被引:93
作者
Bassetti, Matteo
Trecarichi, Enrico Maria
Righi, Elda
Sanguinetti, Maurizio
Bisio, Francesca
Posteraro, Brunella
Soro, Ornella
Cauda, Roberto
Viscoli, Claudio
Tumbarello, Mario
机构
[1] Univ Genoa, Sch Med, Div Infect Dis, S Martino Hosp, I-16132 Genoa, Italy
[2] Univ Cattolica Sacro Cuore, Inst Infect Dis, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy
[4] Univ Genoa, Sch Med, Inst Microbiol, Genoa, Italy
关键词
candidemia; hospital; risk factors; incidence;
D O I
10.1016/j.diagmicrobio.2007.01.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In recent decades, Candida spp. emerged as the fourth most common cause of nosocomial bloodstream infections. The incidence of candidemia was 0. 13 per 100 persons. Eighty-three cases (61 %) of candidemia were due to Candida albicans and 53 (39 %) to nonalbicans Candida spp. Twelve strains of Candida (9 %) had shown in vitro resistance to fluconazole, 5 (4 %) to itraconazole, 2 (1.5 %) to voriconazole, 12 (9 %) to 5-flucytosine, and 1 (0.7%) to amphotericin B. Multivariate logistic regression analysis of risk factors showed that length of hospitalization, presence of a central venous catheter, previous episodes of candidemia or bacteremia, parenteral nutrition, and chronic renal failure were variables independently associated with the development of candidemia. Multivariate logistic regression analysis of prognostic indicators showed that the independent variables associated with poor prognosis were inadequate initial therapy (P < .001) and high APACHE III score (P = .004). The inadequate initial therapy associated with mortality indicates the need for additional investigations to define high-risk patients for beneficial antifungal prophylaxis. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 41 条
[21]   Epidemiology of candidemia in Swiss tertiary care hospitals:: Secular trends, 1991-2000 [J].
Marchetti, O ;
Bille, J ;
Fluckiger, U ;
Eggimann, P ;
Ruef, C ;
Garbino, J ;
Calandra, T ;
Glauser, MP ;
Täuber, MG ;
Pittet, D .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :311-320
[22]  
National Committee for Clinical Laboratory Standards, 2002, M27A2 NAT COMM CLIN
[23]  
Nguyen MH, 1996, AM J MED, V100, P617, DOI 10.1016/S0002-9343(95)00010-0
[24]   A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients [J].
Pappas, PG ;
Rex, JH ;
Lee, J ;
Hamill, RJ ;
Larsen, RA ;
Powderly, W ;
Kauffman, CA ;
Hyslop, N ;
Mangino, JE ;
Chapman, S ;
Horowitz, HW ;
Edwards, JE ;
Dismukes, WE .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (05) :634-643
[25]   Bloodstream infections due to Candida species:: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998 [J].
Pfaller, MA ;
Jones, RN ;
Doern, GV ;
Sader, HS ;
Messer, SA ;
Houston, A ;
Coffman, S ;
Hollis, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :747-751
[26]   Caspofungin activity against clinical isolates of fluconazole-resistant Candida [J].
Pfaller, MA ;
Messer, SA ;
Boyken, L ;
Rice, C ;
Tendolkar, S ;
Hollis, RJ ;
Diekema, DJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) :5729-5731
[27]   Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program [J].
Pfaller, MA ;
Boyken, L ;
Messer, SA ;
Tendolkar, S ;
Hollis, RJ ;
Diekema, DJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (10) :5208-5213
[28]   Twelve years of fluconazole in clinical practice:: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida [J].
Pfaller, MA ;
Diekema, DJ .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 :11-23
[29]   International surveillance of bloodstream infections due to Candida species:: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program [J].
Pfaller, MA ;
Diekema, DJ ;
Jones, RN ;
Sader, HS ;
Fluit, AC ;
Hollis, RJ ;
Messer, SA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (09) :3254-3259
[30]   NOSOCOMIAL BLOOD-STREAM INFECTIONS - SECULAR TRENDS IN RATES, MORTALITY, AND CONTRIBUTION TO TOTAL HOSPITAL DEATHS [J].
PITTET, D ;
WENZEL, RP .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (11) :1177-1184